News

Short, sourced reports on what changed and what happens next. Every post links the primary documents.

Cut-paper illustration of a waterfront bench with a folded blank newspaper and a coffee cup, sailboats and a tall ship in the harbor behind
AI illustration: the morning paper on the waterfront.

We cover psilocybin and related policy as it touches San Diego County: state bills and city votes, federal rules, court cases involving businesses, health warnings about products sold locally, and new research with a San Diego connection. Each post says what happened, with exact dates and figures, why it matters here, and what comes next. Posts never include shop links, and corrections are noted at the bottom of the post. For the background behind the headlines, start with the bill tracker or the map of legal options. Subscribe with the RSS feed.

All news

RSS feed
  1. VA psilocybin trial opens at five sites, none in California

    The VA's PIVOT psilocybin trial for veterans with treatment-resistant depression is recruiting at five sites in four states. None is in California.

  2. Psychedelic measures on the November 3 ballot, and none in California

    Idaho's HJR 4 and psilocybin business bans in Reedsport and Redmond, Oregon, are on the November 3 ballot. California has no statewide psychedelics measure.

  3. Young children's psilocybin ingestions rose sharply, study finds

    Poison-center data show psilocybin ingestions by U.S. children under 6 rose 1,466.7% from 2018 to 2024, a new study found. What San Diego parents should know.

  4. Prop 36 excludes psilocybin as San Diego treatment numbers diverge

    Psilocybin is excluded from Prop 36's hard-drug felony. San Diego's DA and county behavioral health measure treatment differently, with different results.

  5. Oregon's psilocybin centers served 1,511 clients in Q2 2026

    Oregon served 1,511 psilocybin clients in Q2 2026, up from 1,091. License counts, the merger with medical cannabis and fee changes due January 1, 2027.

  6. Federal survey: 9.1 million people used hallucinogens in 2025

    SAMHSA's 2025 survey found 3.1% of people 12 and older, about 9.1 million, used hallucinogens in the past year, up from 2.7% in 2021. No local figures yet.

  7. New Mexico's medical psilocybin rules draw pushback before launch

    New Mexico's proposed medical psilocybin rules drew fire at an October 2 hearing. What critics want changed, and why the start date depends on who you ask.

  8. Nevada City makes psychedelic mushrooms a low police priority

    Nevada City's Resolution 2026-29 deprioritizes adults' personal use of psychedelic mushrooms. What it covers, what it doesn't, and where San Diego stands.

  9. House NDAA would extend military psychedelic studies to 2033

    The House-passed FY2027 defense bill, H.R. 8800, would extend Pentagon psychedelic research to September 30, 2033. It still needs the Senate before it's law.

  10. DEA moves to put five more tryptamines in Schedule I

    DEA's Sept. 23 proposal would put 4-OH-DiPT and four other tryptamines in Schedule I. Comments close October 23. It doesn't cover mushroom-candy compounds.

  11. New Colorado law: ibogaine pilot and natural medicine ad limits

    Colorado's HB26-1325 sets up an ibogaine research pilot, says state law doesn't permit advertising natural medicine, and adds a limited sales license.

  12. Three psychedelic bills stalled in Sacramento; a budget line passed

    SB 1224, AB 2489 and SB 751 stalled in 2026. What each would have done, the veterans' research money that did pass in AB 113, and when lawmakers return.